{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:24:28Z","timestamp":1777890268929,"version":"3.51.4"},"reference-count":28,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2016,10,7]]},"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Breast cancer familial risk clinics offer screening and preventive strategies. While <jats:italic>BRCA1<\/jats:italic>\/<jats:italic>BRCA2<\/jats:italic> genetic testing provides important risk information for some women, panels of more common breast cancer risk genetic variants may have relevance to greater numbers of women with familial risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Three polygenic risk scores (PRS) based on 18 SNPs were investigated in a case\u2013control study of women attending a familial risk clinic. PRS were derived from published general European population allele ORs and frequencies (18-SNPs (SNP18)). In women with <jats:italic>BRCA1<\/jats:italic>\/<jats:italic>BRCA2<\/jats:italic> mutations, 3 SNPs\/13 SNPs, respectively, generated the PRS estimates. In total, 364 incident breast cancer cases (112 with <jats:italic>BRCA1\/2<\/jats:italic> mutations) were matched with 1605 controls (691 <jats:italic>BRCA1\/2<\/jats:italic>) by age last mammogram and <jats:italic>BRCA1\/2<\/jats:italic> genetic test result. 87 women with cancer before attendance were also considered. Logistic regression was used to measure PRS performance through ORs per IQR and calibration of the observed to expected (O\/E) logarithm relative risk when unadjusted and adjusted for phenotypic risk factors assessed by the Tyrer-Cuzick (TC) model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>SNP18 was predictive for non-carriers of <jats:italic>BRCA1\/2<\/jats:italic> mutations (IQR OR 1.55, 95% CI 1.29 to 1.87, O\/E 96%). Findings were unaffected by adjustment from TC (IQR OR 1.56, 95% CI 1.29 to 1.89) or when prior cancers were included (IQR OR 1.55, 95% CI 1.30 to 1.87). There was some evidence to support polygenic scores with weights for individuals with <jats:italic>BRCA1\/2<\/jats:italic> mutations (<jats:italic>BRCA1<\/jats:italic> IQR OR 1.44, 95% CI 1.17 to 1.76; <jats:italic>BRCA2<\/jats:italic> IQ OR 1.44, 95% CI 0.90 to 2.31).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>PRS may be used to refine risk assessment for women at increased familial risk who test negative\/have low likelihood of <jats:italic>BRCA<\/jats:italic>1<jats:italic>\/2<\/jats:italic> mutations. They may alter the recommended prevention strategy for many women attending family history clinics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2016-104125","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T21:54:25Z","timestamp":1477691665000},"page":"111-113","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":60,"title":["The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case\u2013control study"],"prefix":"10.1136","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-5784","authenticated-orcid":false,"given":"D Gareth","family":"Evans","sequence":"first","affiliation":[{"name":"Genesis Breast Cancer Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Manchester, UK"},{"name":"Manchester Centre for Genomic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Central Manchester Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Brentnall","sequence":"additional","affiliation":[{"name":"Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Byers","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Central Manchester Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Harkness","sequence":"additional","affiliation":[{"name":"Centre for Imaging Sciences, Institute for Population Health, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Stavrinos","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Central Manchester Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Howell","sequence":"additional","affiliation":[{"name":"Genesis Breast Cancer Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Manchester, UK"},{"name":"The Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"FH-risk study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G","family":"Newman","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"},{"name":"Central Manchester Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[{"name":"Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,10,28]]},"reference":[{"key":"2025100521103900000_54.2.111.1","unstructured":"Cancer Research UK. http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/incidence\/commoncancers\/ (accessed Feb 2016)."},{"key":"2025100521103900000_54.2.111.2","first-page":"232","article-title":"Genetic analysis of breast cancer in the cancer and steroid hormone study","volume":"48","author":"Claus","year":"1991","journal-title":"Am J Hum Genet"},{"key":"2025100521103900000_54.2.111.3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.9.3044"},{"key":"2025100521103900000_54.2.111.4","doi-asserted-by":"publisher","DOI":"10.1038\/82533"},{"key":"2025100521103900000_54.2.111.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2010.04.011"},{"key":"2025100521103900000_54.2.111.6","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3493"},{"key":"2025100521103900000_54.2.111.7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-155"},{"key":"2025100521103900000_54.2.111.8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt095"},{"key":"2025100521103900000_54.2.111.9","doi-asserted-by":"crossref","unstructured":"Evans DG , Harkness E , Lalloo F , Howell A . Long-term prospective clinical follow-up after BRCA1\/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies. 2014;51:573\u201380. doi:10.1136\/jmedgenet-2014-102336","DOI":"10.1136\/jmedgenet-2014-102336"},{"key":"2025100521103900000_54.2.111.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature05887"},{"key":"2025100521103900000_54.2.111.11","doi-asserted-by":"publisher","DOI":"10.1038\/ng2064"},{"key":"2025100521103900000_54.2.111.12","doi-asserted-by":"publisher","DOI":"10.1038\/ng.586"},{"key":"2025100521103900000_54.2.111.13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2563"},{"key":"2025100521103900000_54.2.111.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1907"},{"key":"2025100521103900000_54.2.111.15","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr226"},{"key":"2025100521103900000_54.2.111.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003212"},{"key":"2025100521103900000_54.2.111.17","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12035"},{"key":"2025100521103900000_54.2.111.18","unstructured":"Easton D , Emery J , Gray J , Halpin J , Hopwood P , McKay J , Sheppard C , Sibbering M , Watson W , Wailoo A , Hutchinson A , McIntosh A , Shaw C , Evans G , Turnbull N , Bahar N , Barclay M , et al . Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. London: National Collaborating Centre for Primary Care\/University of Sheffield. NICE guideline, 2004 (updated 2006, 2013). http:\/\/www.nice.org.uk\/guidance\/cg164"},{"key":"2025100521103900000_54.2.111.19","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.067850"},{"key":"2025100521103900000_54.2.111.20","doi-asserted-by":"crossref","unstructured":"Byers H , Wallis Y , van Veen EM , Lalloo F , Reay K , Smith P , Wallace AJ , Bowers N , Newman WG , Evans DG . Sensitivity of BRCA1\/2 testing in high-risk breast\/ovarian\/male breast cancer families: little contribution of comprehensive RNA\/NGS panel testing. Eur J Hum Genet 2016;24:1591\u201397. doi:10.1038\/ejhg.2016.57","DOI":"10.1038\/ejhg.2016.57"},{"key":"2025100521103900000_54.2.111.21","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"2025100521103900000_54.2.111.22","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.12.865"},{"key":"2025100521103900000_54.2.111.23","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-013-9694-z"},{"key":"2025100521103900000_54.2.111.24","unstructured":"http:\/\/www.cancer.org\/cancer\/breastcancer\/moreinformation\/breastcancerearlydetection\/breast-cancer-early-detection-acs-recs (accessed 23 Jun 2016)."},{"key":"2025100521103900000_54.2.111.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.6607"},{"key":"2025100521103900000_54.2.111.26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv036"},{"key":"2025100521103900000_54.2.111.27","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-0838"},{"key":"2025100521103900000_54.2.111.28","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.747"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2016-104125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:10:51Z","timestamp":1759723851000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2016-104125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,28]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,20]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1136\/jmedgenet-2016-104125"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2016-104125","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,28]]}}}